Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, indicating a site release rather than a change to the study’s content.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:34:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:11:51.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; previous revision was v3.4.2. This appears to be a backend update with no visible changes to the page content.
    Difference
    0.0%
    Check dated 2026-03-12T00:48:04.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the previous government funding notice (the lapse notice with related guidance) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:36:12.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Introduced a site-wide notice regarding a lapse in government funding and updated operating status information for the NIH Clinical Center. The page footer revision changed from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:57:36.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.